4

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: September 14, 2023
Period of Report: September 14, 2023
Accession Number: 0001127602-23-024201

View Document ↗ View on SEC.gov ↗